HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo
about
Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primatesAntiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds.Experimental systems for studying Plasmodium/HIV coinfection.The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei
P2860
HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV treatments reduce malaria ...... elevant concentrations in vivo
@ast
HIV treatments reduce malaria ...... elevant concentrations in vivo
@en
type
label
HIV treatments reduce malaria ...... elevant concentrations in vivo
@ast
HIV treatments reduce malaria ...... elevant concentrations in vivo
@en
prefLabel
HIV treatments reduce malaria ...... elevant concentrations in vivo
@ast
HIV treatments reduce malaria ...... elevant concentrations in vivo
@en
P2093
P2860
P1433
P1476
HIV treatments reduce malaria ...... elevant concentrations in vivo
@en
P2093
Charlotte V Hobbs
Jessica Hinderer
Jillian Neal
Jingyang Chen
Kennan Marsh
Liam Donnelly
Lynn Lambert
Sachy Orr-Gonzalez
Sara Healy
Scott R Penzak
P2860
P304
P356
10.1371/JOURNAL.PONE.0100138
P407
P577
2014-07-02T00:00:00Z